References
- Alberti P. W. Noise and the ear. Scott-Brown's Otolaryngology. 5th edn. Butterworths, Seven Oaks 1987
- Antonelli A., Grandori F. Long term stability influence of the head position and modelling considerations for evoked otoacoustic emissions. Scand Audiol Suppl 1986; 25: 97–108
- Avan P., Bonfils P., Loth D., Narcy P., Trotoux J. Quantitative assessment of human cochlear function by evoked otoacoustic emissions. Hear Res 1991; 52: 99–112
- Avan P., Bonfils P. Frequency specificity of human distortion product otoacoustic emissions. Audiology, in press
- Beck A., Maurer J., Welkoborsky H. J., Mann W. Veränderungen transitorisch evozierte otoakustischer Emissionen unter Chemotherapie mit Cisplatin und 5FU. HNO 1992; 40: 123–7
- Brown A. M., McDowell B., Forge A. Acoustic distortion products can be used to monitor the effects of chronic gentamicin treatment. Hear Res 1989; 42: 143–56
- Cane M. A., O'Donoghue G. M., Lutman M. E. The feasibility of using otoacoustic emissions to monitor cochlear function during acoustic neuroma surgery. Scand Audiol 1992; 21: 173–6
- Davis H. An active process in cochlear mechanics. Hear Res 1983; 9: 79–0
- Harris F. P., Probst R., Wenger R. Repeatability of transiently evoked otoacoustic emissions in normally hearing humans. Audiology 1991; 30: 135–41
- Harris F. P., Probst R. Reporting click-evoked and distortion-product otoacoustic emission results with respect to the pure-tone audiogram. Ear Hear 1991; 12: 399–405
- Hauser R., Probst R., Harris F. P., Frei F. Influence of general anesthesia on transiently evoked otoacoustic emissions in humans. Ann Otol Rhind Laryngol 1992; 101: 994–9
- Hinchcliffe R. Epidemiology of hearing. Auditory Investigation: The Scientific and Technological Basis, H. A. Beagley. Clarendon Press, Oxford 1979; 552–95
- Hotz M. A., Probst R., Harris F. P., Hauser R. Monitoring the effect of noise exposure using transiently evoked otoacoustic emissions. Acta Otolaryngol, in press
- Karlsson K. K., Berninger E., Alvan G. The effect of quinine on psychoacoustic tuning curves stapedius reflexes and evoked otoacoustic emissions in healthy volunteers. Scand Audiol 1991; 20: 83–90
- Kemp D. T. Stimulated acoustic emissions from within the human auditory system. J Acoust Soc Am 1978; 64: 1386–91
- Kemp D. T. Development in cochlear mechanics and techniques for noninvasive evaluation. Adv Audiol 1988; 5: 27–45
- Long G. R., Tubis A. Modification of spontaneous and evoked otoacoustic emissions and associated psychoacoustic microstructure by aspirin consumption. J Acoust Soc Am 1988; 84: 1343–54
- Lonsbury-Martin B. L., Martin G. K. The clinical utility of distortion-product otoacoustic missions. Ear Hear 1990; 11: 144–54
- Lonsbury-Martin B. L., Cutler W. N., Martin G. K. Evidence for the influence of aging on distortion-product otoacoustic emissions. J Acoust Soc Am 1991; 89: 1749–59
- Martin G. K., Stagner B. B., Coats A. C., Lonsbury-Martin B. L. Endolymphatic hydrops in rabbit-behavioral thresholds, acoustic distortion products, and cochlear pathology. Second International Symposium on Menière's Disease, J. B. Nadol, Jr. Kugler, Amsterdam 1989; 205–19
- Martin G. K., Ohlms L. A., Franklin D. J., Harris F., Lonsbury-Martin B. L. Distortion product emissions in humans. III. Influence of sensorineural hearing loss. Ann Otol Rhinol Laryngol Suppl 1990; 236: 29–44
- McCoy M. J., Franklin D. J., Lonsbury-Martin B. L., Martin G. K. Evoked otoacoustic emissions: test-retest reliability. ASHA 1990; 32: 156
- McFadden D., Plattsmier H. S. Aspirin abolishes spontaneous otoacoustic cmissions. J Acoust Soc Am 1984; 76: 443–8
- Nelson D. A., Kimberley B. P. Distortion-product emissions and auditory sensitivity in human ears with normal hearing and cochlear hearing loss. J Speech Hear Res 1992; 35: 1142–59
- Norton S. J., Mott J. B., Champlin C. A. Behavior of spontaneous otoacoustic emissions following intense acoustic stimulation. Hear Res 1989; 38: 243–58
- Norton S. J., Bargones J. Y., Rubel E. W. Development of otoacoustic emissions in gerbil: evidence for micromcchanical changes underlying development of the place code. Hear Res 1991; 51: 73–92
- Plinkert P. K., Kröber S. Früherkennung einer Cisplatinum-Otoloxizität durch evozierte otoakustische Emissionen. Laryngorhinootologie 1991; 70: 457–62
- Probst R., Lonsbury-Martin B. L., Martin G. K. A review of otoacoustic emissions. J Acoust Soc Am 1991; 89: 2027–67
- Probst R., Harris F. P. A comparison of transiently-evoked and distortion-product otoacoustic emissions. Exp Brain Res, in press
- Probst R., Hauser R. Distortion product otoacoustic emissions in normal and hearing-impaired ears. Am J Otolaryngol 1990; 11: 236–43
- Roede J., Harris F. P., Probst R., Xu L. The repeatability of distortion-product otoacoustic emissions in normally hearing humans. Audiology, in press
- Rossi G., Solero P., Rolando M., Olina M. Recovery time of the temporary threshold shift for delayed evoked otoacoustic emissions and tone bursts. ORL 1991; 53: 15–8
- Smurzynski J., Leonard G., Kim D. O., Lafreniere D., Jung M. Distortion product otoacoustic emissions in normal and impaired adult ears. Arch Otolaryngol Head Neck Surg 1990; 116: 1309–16
- Spillmann T., Prestele C., Custer P. Das Schadenrisiko des Ohres im Rahmen der militärischen Grun-dausbildung in der Schweiz. ORL Aktuelle Probleme der Otorhinolaryngologie 1990; 13: 288–95
- Whitehead M. L., Lonsbury-Martin B. L., Martin G. K. Relevance of animal models to the clinical application of otoacoustic emissions. Semin Hear 1992; 13: 81–101
- Wier C. C., Pasanen E. G., McFadden D. Partial dissociation of spontaneous otoacoustic emissions and distortion products during aspirin use in humans. J Acoust Soc Am 1988; 84: 230–7